Yayınlar & Eserler

Yayın Ağı
Makaleler 18
Tümü (18)
SCI-E, SSCI, AHCI (14)
SCI-E, SSCI, AHCI, ESCI (15)
ESCI (1)
Scopus (18)
TRDizin (1)

1. The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school

Gülmez S. E., Özcan G., Orer H. S.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , cilt.92, sa.8, ss.2465-2473, 2026 (SCI-Expanded, Scopus)

2. Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy

Leylek O., Honeywell M. E., Lee M. J., Hemann M. T., Özcan G.
GASTRIC CANCER , cilt.27, sa.6, ss.1201-1219, 2024 (SCI-Expanded, Scopus)

3. Brain lymphatic vessels accompanying meningeal arteries in the human

Çavdar S., Altınöz D., Demir T. D., Bayraktaroğlu A., Gürses İ. A., ÖZCAN G.
Translational Research in Anatomy , cilt.37, 2024 (Scopus)

4. Extracranial transport of brain lymphatics via cranial nerve in human

Çavdar S., Altınöz D., Dilan Demir T., Ali Gürses İ., ÖZCAN G.
Neuroscience Letters , cilt.827, 2024 (SCI-Expanded, Scopus)

5. Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer

Ozmen E., Demir T. D., Özcan G.
FRONTIERS IN MOLECULAR BIOSCIENCES , cilt.11, ss.1-18, 2024 (SCI-Expanded, Scopus)

6. The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting

ÖZCAN G.
Frontiers in Cell and Developmental Biology , cilt.11, 2023 (SCI-Expanded, Scopus)

7. PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer

ÖZCAN G.
Frontiers in Oncology , cilt.13, 2023 (SCI-Expanded, Scopus)

8. SCUBE2 as a Marker of Resistance to Taxane-based Neoadjuvant Chemotherapy and a Potential Therapeutic Target in Breast Cancer

ÖZCAN G.
European Journal of Breast Health , cilt.19, sa.1, ss.45-54, 2023 (ESCI, Scopus, TRDizin)

9. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer

Ucaryilmaz Metin C., ÖZCAN G.
BMC Cancer , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

10. The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer

Metin C. U., ÖZCAN G.
Cancers , cilt.14, sa.11, 2022 (SCI-Expanded, Scopus)

11. Achieving synergism in combination chemotherapy for gastric cancer treatment

Leylek O., Ozcan G.
MOLECULAR CANCER THERAPEUTICS , cilt.20, sa.12, 2021 (SCI-Expanded, Scopus)

12. Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity

Almammadov T., Atakan G., Leylek O., ÖZCAN G., GÜNBAŞ E. G., Kolemen S.
ACS Medicinal Chemistry Letters , cilt.11, sa.12, ss.2491-2496, 2020 (SCI-Expanded, Scopus)

13. Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation

ÖZCAN G., Aykac E., Kasap Y., Nemutlu N. T., Sen E., Aydinkarahaliloglu N. D.
Drugs - Real World Outcomes , cilt.3, sa.1, ss.33-43, 2016 (Scopus)

14. Effect of Nitric oxide on cardiacfunction: Review Nitrik oksidin kalp Işlevleri üzerine etkisi

Özcan G., Şahin E. A., DEMİREL YILMAZ E.
Turkiye Klinikleri Cardiovascular Sciences , cilt.28, sa.3, ss.99-117, 2016 (Scopus) Sürdürülebilir Kalkınma

15. Preclinical and clinical development of siRNA-based therapeutics

ÖZCAN G., Ozpolat B., Coleman R. L., Sood A. K., Lopez-Berestein G.
Advanced Drug Delivery Reviews , cilt.87, ss.108-119, 2015 (SCI-Expanded, Scopus)

16. Various Phosphodiesterase Activities in Different Regions of the Heart Alter the Cardiac Effects of Nitric Oxide

DEMİREL YILMAZ E., Cenik B., Ozcan G., Derici M. K.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY , cilt.60, sa.3, ss.283-292, 2012 (SCI-Expanded, Scopus)

17. Cell Contact-dependent Functional Selectivity of beta(2)-Adrenergic Receptor Ligands in Stimulating cAMP Accumulation and Extracellular Signal-regulated Kinase Phosphorylation

Kaya A. I., ONARAN H. O., Ozcan G., Ambrosio C., Costa T., Balli S., et al.
JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.287, sa.9, ss.6362-6374, 2012 (SCI-Expanded, Scopus) Creative Commons License

18. beta(2)-Adrenoceptor, Gs and adenylate cyclase coupling in purified detergent-resistant, low density membrane fractions

Oner S. S., Kaya A. I., ONARAN H. O., Ozcan G., Ugur O.
EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.630, sa.1-3, ss.42-52, 2010 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. The integration of the British Pharmacological Society's Prescription Safety Assessment into the Groningen Model of Rational Pharmacotherapy in a Turkish Medical School

Orer H., Ozcan G., Gulmez S. E.
19th World Congress of Basic and Clinical Pharmacology (WCP), Glasgow, İngiltere, 2 - 07 Temmuz 2023, cilt.180, ss.624-625, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Implementation of the British Pharmacological Society's Prescribing Safety Assessment (PSA) in a Turkish Medical School for Interns

Gulmez S. E., Ozcan G., Orer H.
19th World Congress of Basic and Clinical Pharmacology (WCP), Glasgow, İngiltere, 2 - 07 Temmuz 2023, cilt.180, ss.623-624, (Özet Bildiri) Sürdürülebilir Kalkınma

3. A Distinctive Stromal Reaction as the Herald of Uncertain Carcinoma Foci in the Peritoneal Frozen Sections of Post-Neoadjuvant Gastric Poorly Cohesive /Signet Ring Cell Carcinomas

Aktas B. K., Esmer R., Tezcan N., Taskin O., Armutlu A., Saka B., et al.
112th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Meksika, 11 - 16 Mart 2023, cilt.103, (Özet Bildiri)

4. Fourth-year rational pharmacotherapy clerkship at Koc University School of Medicine

Gulmez S. E., Ozcan G., Orer H. S.
14th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics (EACPT), Stockholm, İsveç, 29 Haziran - 02 Temmuz 2019, cilt.75, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Concomitant Drug Use as a Contributing Factor for Developing Cardiovascular Adverse Reactions with Trandolapril/Verapamil Combination

Ozcan G., Aykac E., Kasap Y., Sen E., Nemutlu N., Artiran G., et al.
13th Annual Meeting of the International-Society-of-Pharmacovigilance (ISoP) - The Renaissance of Pharmacovigilance, Pisa, İtalya, 1 - 04 Ekim 2013, cilt.36, ss.845, (Özet Bildiri) Sürdürülebilir Kalkınma
Kitaplar 1

1. Clinical Development of HIF-1α inhibitors for Cancer Therapy

ÖZCAN G.
Medical Diagnosis and Treatment Methods in Basic Medical Sciences, Keskin Sıddık, Editör, Livre de Lyon, Lyon, ss.25-37, 2020
Metrikler

Yayın

24

Yayın (WoS)

20

Yayın (Scopus)

18

Atıf (WoS)

675

H-İndeks (WoS)

7

Atıf (Scopus)

755

H-İndeks (Scopus)

8

Proje

5

Tez Danışmanlığı

4

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER